VJHemOnc Podcast

Feb 27 2025 275 ep. 19 mins 26

The Video Journal of Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts - from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases.
Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion.
If you enjoy the podcast, please leave us a rating and review!
For more news visit www.vjhemonc.com

Health & Fitness

Copy RSS

Subscribe on Podcast Addict

CAR T-cell therapy in ALL: trial updates, novel approaches, & real-world outcomes

Feb 27 2025 18 mins

CAR T-cell therapy has become an established treatment for several hematological malignancies, including acute lymphoblastic leukemia (ALL), and has significantly...

Post-ASH amyloidosis highlights: the ANDROMEDA trial, risk stratification, value of MRD, & more!

Feb 21 2025 13 mins

Today’s podcast features a discussion with experts Vaishali Sanchorawala, MD, Boston University School of Medicine, Boston, MA, and Ashutosh Wechalekar,...

Post-ASH non-malignant highlights: updates in sickle cell disease, thalassemia, and hemophilia

Feb 14 2025 18 mins

This episode of the VJHemOnc podcast covers updates in non-malignant hematological diseases from the 66th American Society of Hematology (ASH)...

Post-ASH myeloma highlights: key takeaways for community physicians & trials to look out for in 2025

Feb 06 2025 18 mins

This podcast brings you exclusive updates on multiple myeloma from the 66th American Society of Hematology (ASH) Annual Meeting and...

Post-ASH AML highlights: novel approaches to frontline therapy, advances with menin inhibitors, & managing FLT3-ITD+ AML

Jan 31 2025 29 mins

In this podcast, we bring you exclusive updates in acute myeloid leukemia (AML) from the 66th American Society of Hematology...

Post-ASH MPN highlights: key trial updates in MF, novel approaches being explored in R/R disease, & more!

Jan 28 2025 22 mins

This podcast episode covers highlights in myeloproliferative neoplasms (MPNs) from the 66th American Society of Hematology (ASH) Annual Meeting and...

Post-ASH NHL highlights: novel combinations in the frontline setting and advancements with immunotherapy in the R/R setting

Jan 24 2025 31 mins

Today’s podcast showcases key updates in non-Hodgkin lymphoma (NHL) from the 66th American Society of Hematology (ASH) Annual Meeting and...

Post-ASH MDS highlights: managing anemia in LR-MDS and novel approaches to treating HR-MDS

Jan 17 2025 19 mins

This podcast is the second episode in our series spotlighting key highlights from the 66th American Society of Hematology (ASH)...

Post-ASH CLL highlights: BTK inhibitors & degraders, bispecific antibodies, & more!

Jan 10 2025 16 mins

VJHemOnc recently attended the 66th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego, CA, where we...

Advancing treatment for BPDCN: current therapies, a deep dive into tagraxofusp, & emerging novel agents

Dec 18 2024 28 mins

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy characterized by involvement of the skin, bone...